Skip to main content
. 2010 Jun;27(6):999–1006. doi: 10.1089/neu.2009.1129

Table 4.

Functional Outcome of Glasgow Outcome Score from 3 to 24 Months Based on NGB Genotypes on rs3783988 and rs10133981

 
rs3783988
rs10133981
  Present (CC/CT) Absent (TT) p Present (TT/GT) Absent (GG) p
3 Months     0.02E     0.16E
 1 23 (40.4%) 19 (19.2%)   2 (20.0%) 38 (26.4%)  
 2 5 (8.8%) 9 (9.1%)   3 (30.0%) 11 (7.6%)  
 3 21 (36.8%) 41 (41.4%)   3 (30.0%) 60 (41.7%)  
 4 8 (14.0%) 22 (22.2%)   1 (10.0%) 29 (20.1%)  
 5 0 (0.0%) 8 (8.1%)   1 (10.0%) 6 (4.2%)  
Poor (1–3) 49 (86.0%) 69 (69.7%) 0.02C 8 (80.0%) 109 (75.7%) 1.00F
Good (4–5) 8 (14.0%) 30 (30.3%)   2 (20.0%) 35 (24.3%)  
6 Months     0.11E     0.42E
 1 20 (37.0%) 21 (21.6%)   3 (25.0%) 36 (26.5%)  
 2 4 (7.4%) 6 (6.2%)   2 (16.7%) 8 (5.9%)  
 3 17 (31.5%) 26 (26.8%)   4 (33.3%) 39 (28.7%)  
 4 8 (14.8%) 26 (26.8%)   3 (25.0%) 31 (22.8%)  
 5 5 (9.3%) 18 (18.6%)   0 (0.0%) 22 (16.2%)  
Poor (1–3) 41 (75.9%) 53 (54.6%) 0.01C 9 (75.0%) 83 (61.0%) 0.54F
Good (4–5) 13 (24.1%) 44 (45.4%)   3 (25.0%) 53 (39.0%)  
12 Months     0.02E      
 1 17 (32.7%) 19 (23.5%)   1 (10.0%) 34 (28.1%) 0.33E
 2 4 (7.7%) 5 (6.2%)   1 (10.0%) 8 (6.6%)  
 3 18 (34.6%) 15 (18.5%)   5 (50.0%) 28 (23.1%)  
 4 9 (17.3%) 19 (23.5%)   2 (20.0%) 25 (20.7%)  
 5 4 (7.7%) 23 (28.4%)   1 (10.0%) 26 (21.5%)  
Poor (1–3) 39 (75.0%) 39 (48.1%)  <0.01C 7 (70.0%) 70 (57.9%) 0.52F
Good (4–5) 13 (25.0%) 42 (51.9%)   3 (30.0%) 51 (42.1%)  
24 Months     0.24E     0.34E
 1 16 (47.1%) 18 (27.3%)   1(14.3%) 32 (35.2%)  
 2 1 (2.9%) 3 (4.5%)   1 (14.3%) 3 (3.3%)  
 3 7 (20.6%) 11 (16.7%)   2 (28.6%) 16 (17.6%)  
 4 4 (11.8%) 12 (18.2%)   2 (28.6%) 14 (15.4%)  
 5 6 (17.6%) 22 (33.3%)   1 (14.3%) 26 (28.6%)  
Poor (1–3) 24 (70.6%) 32 (48.5%) 0.04C 4 (57.1%) 51 (56.0%) 1.00F
Good (4–5) 10 (29.4%) 34 (51.5%)   3 (42.9%) 40 (44.0%)  

F, Fisher's exact test; C, chi-square test; E, exact test.